T
Theresa Wampler Muskardin
Researcher at New York University
Publications - 26
Citations - 917
Theresa Wampler Muskardin is an academic researcher from New York University. The author has contributed to research in topics: Internal medicine & Disease. The author has an hindex of 12, co-authored 21 publications receiving 569 citations. Previous affiliations of Theresa Wampler Muskardin include University of Minnesota & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Febrile infection-related epilepsy syndrome treated with anakinra.
Daniel L. Kenney-Jung,Annamaria Vezzani,Robert J. Kahoud,Reghann G. LaFrance-Corey,Mai-Lan Ho,Theresa Wampler Muskardin,Elaine C. Wirrell,Charles L. Howe,Eric T. Payne +8 more
TL;DR: Cerebral spinal fluid analysis revealed elevated levels of proinflammatory cytokines before treatment that normalized on anakinra, suggesting a potential pathogenic role for neuroinflammation in FIRES.
Journal ArticleDOI
Type I interferon in rheumatic diseases
TL;DR: The type I interferon pathway has been implicated in the pathogenesis of a number of rheumatic diseases, including systemic lupus erythematosus, Sjögren syndrome, myositis, systemic sclerosis, and rheumatoid arthritis.
Journal ArticleDOI
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
Adriana Almeida de Jesus,Yangfeng Hou,Stephen R. Brooks,Louise Malle,Angelique Biancotto,Yan Huang,Katherine R. Calvo,Bernadette Marrero,Susan Moir,Andrew J. Oler,Zuoming Deng,Gina A. Montealegre Sanchez,Amina Ahmed,Eric J. Allenspach,Bita Arabshahi,Edward M. Behrens,Susanne M. Benseler,Liliana Bezrodnik,Sharon Bout-Tabaku,Anne Marie C. Brescia,Diane E. Brown,Jon M. Burnham,María Soledad Caldirola,Ruy Carrasco,Alice Y. Chan,Rolando Cimaz,Paul Dancey,Jason Dare,Marietta DeGuzman,Victoria R. Dimitriades,Ian Ferguson,Polly J. Ferguson,Laura S. Finn,Marco Gattorno,Alexei A. Grom,Eric P. Hanson,Philip J. Hashkes,Christian M. Hedrich,Ronit Herzog,Gerd Horneff,Rita Jerath,Elizabeth A. Kessler,Hanna Kim,Daniel J. Kingsbury,Ronald M. Laxer,Pui Y. Lee,Min Ae Lee-Kirsch,Laura B Lewandowski,Suzanne C. Li,Vibke Lilleby,Vafa Mammadova,Lakshmi N. Moorthy,Gulnara Nasrullayeva,Kathleen M. O'Neil,Karen Onel,Seza Ozen,Nancy Pan,Pascal Pillet,Daniela Gerent Petry Piotto,Marilynn Punaro,Andreas Reiff,Adam L Reinhardt,Lisa G. Rider,Rafael Rivas-Chacon,Tova Ronis,Angela Rösen-Wolff,Johannes Roth,Natasha M. Ruth,Marite Rygg,Heinrike Schmeling,Grant S. Schulert,Christiaan Scott,Gisella Seminario,Andrew I. Shulman,Vidya Sivaraman,Mary Beth F. Son,Yuriy Stepanovskiy,Elizabeth Stringer,Sara Taber,Maria Teresa Terreri,Cynthia J. Tifft,Troy R. Torgerson,Laura L. Tosi,Annet van Royen-Kerkhof,Theresa Wampler Muskardin,Scott W. Canna,Raphaela Goldbach-Mansky +86 more
TL;DR: The IRG-S expands the diagnostic armamentarium in evaluating USAIDs and points to different pathways regulating IRG expression as well as 3 additional autoinflammatory diseases: IL-18-mediated PAP and recurrent MAS, NEMO∆5-associated autoinflammatory syndrome (NEMO-NDAS), and SAMD9L- associated autoinflammatory disease (SAMD 9L-SAAD).
Journal ArticleDOI
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
Aaron Z Reyes,Kelly A Hu,Jacob Teperman,Theresa Wampler Muskardin,Jean-Claude Tardif,Binita Shah,Michael H. Pillinger +6 more
TL;DR: Colchicine is easily administered, generally well tolerated and inexpensive, and holds particular promise to reduce the risk of hospitalisation and mortality due to COVID-19 in the outpatient setting, to the benefit of both resource-replete and resource-poor regions.
Journal ArticleDOI
Castleman disease and associated autoimmune disease
TL;DR: Advances in understanding of pathogenic cell types and cytokines in Castle man disease have allowed the development of targeted therapies successful in the treatment of both Castleman disease and associated autoimmune disease.